Takeuchi, Masahiro
Astellas Pharma (Japan)
2 papers on CoChatORCID 0000-0002-3520-7402
Most cited papers
- Verified
Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes
Makino, H., Haneda, M., Babazono, T., Moriya, T., Ito, S., Iwamoto, Y., Kawamori, R., Takeuchi, M., Katayama, S., & for the INNOVATION Study Group (2007) · Diabetes Care
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 230
- Verified
Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression
Tanaka, H., Sakagami, H., Kaneko, N., Konagai, S., Yamamoto, H., Matsuya, T., Yuri, M., Yamanaka, Y., Mori, M., Takeuchi, M., et al. (2019) · Molecular Cancer Therapeutics
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free